Tianjin Pharma DRT (SH600329)

CN
CNEN
Group Profile
Group Introduction
History
Corporate Culture
Group Industry
ESG
Brand Story
Brand Story
Product Center
Product Family
Products and Services
Group News
Group News
Health Services
Brand Display
Health Information
Investor Relations
Stock Information
Company Announcements
Investor Contact
Join Us
Talent Concept
Recruitment Information
Contact Us
Contact Us

Tianjin Pharma DRT (SH600329)

35.17 +0.35 +1.01%

CNEN
Home Page
Group Profile
Group IntroductionHistoryCorporate CultureGroup IndustryESG
Brand Story
Product Center
Product FamilyProducts and Services
Group News
Health Services
Brand DisplayHealth Information
Investor Relations
Stock InformationCompany AnnouncementsInvestor Contact
Join Us
Talent ConceptRecruitment Information
Contact Us

Online Mall
Product Center
Product Family
Home Page Product Center Product Family
Product Family
Products and Services
Mai An Granule

Treatment for hyperlipoproteinemia. Used to lower serum cholesterol, prevent atherosclerosis, and has a certain effect on lowering triglycerides and β-lipoproteins.

We are the Leader of Chinese Medicine and Striving to Become a Leader in Innovative Medicine in China
Group Profile
Brand Story
Product Center
Group News
Health Services
Investor Relations
Join Us
Contact Us
Address: 78 Shenton Way, #19-02
Singapore：079120
Tel：+65 6514 0579
Fax：+65 6514 0439
JICPB No. 2022007352 JGWAB No.12010402000399
Internet Drug Information Service Qualification Certificate No.: (Tianjin) - Non operational -2020-0021
© 2023 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Powered by xinhongru.
Privacy Policy Legal Statement